Suppr超能文献

12项多发性硬化症步行量表的意大利语验证

Italian validation of the 12-item multiple sclerosis walking scale.

作者信息

Solaro C, Trabucco E, Signori A, Cella M, Messmer Uccelli M, Brichetto G, Cavalla P, Gironi M, Patti F, Prosperini L

机构信息

Neurology Unit, Head and Neck Department, ASL 3 "Genovese", 16154 Genova, Italy.

Neurology Unit, Head and Neck Department, ASL 3 "Genovese", 16154 Genova, Italy ; Department of Experimental Medicine, Section of Diagnostic Radiology, University of Genoa, 16126 Genova, Italy.

出版信息

Mult Scler Int. 2015;2015:540828. doi: 10.1155/2015/540828. Epub 2015 Mar 26.

Abstract

Objective. Gait impairment is commonly in people with multiple sclerosis (MS). The 12-item MS walking scale (MSWS-12) assesses patients' measurement of walking quality. The aim of this study was to cross-culturally adapt and validate the MSWS-12 for the Italian population with MS. Methods. Six MS out-patient clinics across Italy enrolled subjects between June 2013 and December 2013. Construct validity of MSWS-12 was determined by examining correlations with the Italian version of the EDSS, the timed 25-foot walk (T25FW), and the Fatigue Severity Scale (FSS). Results. 321 MS subjects were enrolled. Mean age was 47.55 years and mean disease duration was 13.8 years. Mean EDSS score was 4.46. 185 subjects had a relapsing-remitting course, 92 were secondary progressive, 43 were primary progressive, and 1 had a clinically isolated syndrome. The mean total score of the MSWS-12 was 49.6 (SD: 31) with values ranging between 0 and 100. Correlations between the MSWS-12 with age, disease duration, and disease course were found but not with gender. Values of the MSWS-12/IT were significantly related to EDSS (0.71), to the T25FW (0.65), and to the FSS (0.51). Conclusion. MSWS-12/IT has been adapted and validated, it is a reliable and reproducible scale for Italian patients with MS.

摘要

目的。步态障碍在多发性硬化症(MS)患者中很常见。12项MS步行量表(MSWS - 12)用于评估患者对步行质量的测量。本研究的目的是对MSWS - 12进行跨文化改编并验证其在意大利MS患者群体中的有效性。方法。2013年6月至2013年12月期间,意大利的6家MS门诊招募了受试者。通过检查与意大利版扩展残疾状态量表(EDSS)、25英尺定时步行(T25FW)和疲劳严重程度量表(FSS)的相关性来确定MSWS - 12的结构效度。结果。共招募了321名MS受试者。平均年龄为47.55岁,平均病程为13.8年。平均EDSS评分为4.46。185名受试者为复发缓解型病程,92名为继发进展型,43名为原发进展型,1名患有临床孤立综合征。MSWS - 12的平均总分是49.6(标准差:31),取值范围在0到100之间。发现MSWS - 12与年龄、病程和疾病类型之间存在相关性,但与性别无关。MSWS - 12/IT的值与EDSS(0.71)、T25FW(0.65)和FSS(0.51)显著相关。结论。MSWS - 12/IT已完成改编和验证,它是用于意大利MS患者的可靠且可重复的量表。

相似文献

1
Italian validation of the 12-item multiple sclerosis walking scale.
Mult Scler Int. 2015;2015:540828. doi: 10.1155/2015/540828. Epub 2015 Mar 26.
2
Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2.
Mult Scler Relat Disord. 2024 Sep;89:105768. doi: 10.1016/j.msard.2024.105768. Epub 2024 Jul 11.
4
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
J Neurol Sci. 2013 Dec 15;335(1-2):169-73. doi: 10.1016/j.jns.2013.09.024. Epub 2013 Sep 24.
5
Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
Mult Scler Relat Disord. 2024 Aug;88:105715. doi: 10.1016/j.msard.2024.105715. Epub 2024 Jun 9.
6
Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
Health Qual Life Outcomes. 2023 Oct 9;21(1):110. doi: 10.1186/s12955-023-02190-2.
8
Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
Mult Scler Relat Disord. 2022 Oct;66:104034. doi: 10.1016/j.msard.2022.104034. Epub 2022 Jul 5.
9
The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
Qual Life Res. 2016 Dec;25(12):3221-3230. doi: 10.1007/s11136-016-1342-2. Epub 2016 Jun 24.
10
Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS.
Neurology. 2013 Apr 16;80(16):1509-17. doi: 10.1212/WNL.0b013e31828cf7f3. Epub 2013 Mar 27.

引用本文的文献

1
Motor and cognitive changes across 2 years: a longitudinal study in early Multiple Sclerosis.
Arch Physiother. 2025 Jul 1;15:174-183. doi: 10.33393/aop.2025.3254. eCollection 2025 Jan-Dec.
3
Assessing disease progression and treatment response in progressive multiple sclerosis.
Nat Rev Neurol. 2024 Oct;20(10):573-586. doi: 10.1038/s41582-024-01006-1. Epub 2024 Sep 9.
4
Walking performance differs between people with multiple sclerosis who perform distinct types of exercise.
Neurodegener Dis Manag. 2024;14(3-4):75-85. doi: 10.1080/17582024.2024.2389037. Epub 2024 Aug 19.
5
Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
Health Qual Life Outcomes. 2023 Oct 9;21(1):110. doi: 10.1186/s12955-023-02190-2.
8
Walking With Horizontal Head Turns Is Impaired in Persons With Early-Stage Multiple Sclerosis Showing Normal Locomotion.
Front Neurol. 2022 Jan 28;12:821640. doi: 10.3389/fneur.2021.821640. eCollection 2021.
10
Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale.
Mult Scler J Exp Transl Clin. 2017 Sep 1;3(3):2055217317728740. doi: 10.1177/2055217317728740. eCollection 2017 Jul-Sep.

本文引用的文献

2
Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters.
Arch Phys Med Rehabil. 2013 Mar;94(3):575-8. doi: 10.1016/j.apmr.2012.08.214. Epub 2012 Sep 5.
4
Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12.
J Neurol Sci. 2011 Jun 15;305(1-2):75-9. doi: 10.1016/j.jns.2011.03.008. Epub 2011 Apr 6.
5
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
7
Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
J Neurol Sci. 2008 May 15;268(1-2):69-73. doi: 10.1016/j.jns.2007.11.003. Epub 2007 Dec 3.
8
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
Mult Scler. 2008 Apr;14(3):383-90. doi: 10.1177/1352458507082607. Epub 2007 Oct 17.
9
Fear of falling and associated activity curtailment among middle aged and older adults with multiple sclerosis.
Mult Scler. 2007 Nov;13(9):1168-75. doi: 10.1177/1352458507079260. Epub 2007 Sep 19.
10
Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
Neurology. 2004 Jun 8;62(11):2103-5. doi: 10.1212/01.wnl.0000127604.84575.0d.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验